BiomX Inc.
PHGE · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $1,803 | $871 | $0 | $0 |
| Gross Profit | -$1,803 | -$871 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $24,663 | $19,035 | $16,244 | $22,676 |
| G&A Expenses | $11,776 | $0 | $9,456 | $11,267 |
| SG&A Expenses | $11,776 | $7,779 | $9,456 | $11,267 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $785 | $0 | $1,519 | $1,519 |
| Operating Expenses | $37,224 | $26,814 | $27,219 | $35,462 |
| Operating Income | -$39,027 | -$27,685 | -$27,219 | -$35,462 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $21,313 | $1,539 | -$1,033 | -$697 |
| Pre-Tax Income | -$17,714 | -$26,146 | -$28,252 | -$36,159 |
| Tax Expense | $13 | $23 | $65 | $67 |
| Net Income | -$17,727 | -$26,169 | -$28,317 | -$36,226 |
| % Margin | – | – | – | – |
| EPS | -27.93 | -96.9 | -180.31 | -264.67 |
| % Growth | 71.2% | 46.3% | 31.9% | – |
| EPS Diluted | -27.93 | -96.9 | -180.31 | -264.67 |
| Weighted Avg Shares Out | 3,674 | 2,702 | 1,571 | 1,369 |
| Weighted Avg Shares Out Dil | 691,479 | 2,702 | 1,571 | 1,369 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,048 | $1,122 | $902 | $2 |
| Interest Expense | $2,786 | $2,404 | $2,069 | $699 |
| Depreciation & Amortization | $1,803 | $871 | $2,520 | $2,565 |
| EBITDA | -$13,125 | -$22,815 | -$23,663 | -$32,895 |
| % Margin | – | – | – | – |